Based on the expression of several specific molecular receptors, breast cancers are classified into three distinct molecular subtypes as follows: hormone receptor (HR)+/Luminal, HER2-enriched, and triple-negative breast cancer (TNBC). Here, ERBB2 is linked to breast carcinoma.